Treatment Response to Different Lymphoedema Compression Programs Using a Pneumatic Compression Device

Exclusion Criteria

• •Diagnosis of active or recurrent cancer, or less than 3 months at the time of initial evaluation from the completion of chemotherapy, radiation therapy, or primary surgery for the treatment of cancer
• •Active infection or inflammation
• •Active thrombophlebitis (within the last 2 months)
• •History of pulmonary embolism (within the last 2 months)
• •Documented history of deep chronic venous insufficiency or deep venous obstruction with a reflux duration of \> 2 second in the deep system or any history of deep vein thrombosis (DVT)
• •History of pulmonary edema
• •History of congestive heart failure
• •History of chronic kidney disease with a glomerular filtration rate (GFR) of less than 30 mls per minute
• •Poorly controlled asthma
• •Symptomatic or severe peripheral artery disease (defined by current lifestyle-limiting claudication or critical limb ischemia)
• •Presence of an open wound or ulcer of any etiology
• •Diagnosis of lipoedema and lipolymphoedema
• •Currently using an in-home pneumatic compression device
• •Metal implant(s) that would interfere with bioimpedance equipment
• •Pacemaker or other implanted electronic device(s)
• •Unable or unwilling to remove bandaging from treatment regimen while participating in the study
• •Pregnant
• •Any condition where increased venous and lymphatic return is undesirable
• •Unable or unwilling to participate in all aspects of the study protocol and/or unable to provide informed consent
• •Currently participating in another clinical trial
• •Currently using diuretics
• •BMI \> 40